Trials / Conditions / Small Lymphocytic Leukemia (SLL)

Small Lymphocytic Leukemia (SLL)

4 registered clinical trials studyying Small Lymphocytic Leukemia (SLL) — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Phase II Study of Combined Pirtobrutinib, Venetoclax and Obinutuzumab (PVO) Time-limited Treatment for Patient NCT06967610	M.D. Anderson Cancer Center	Phase 2
Terminated	Duvelisib for Ibrutinib-Resistant Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma NCT04209621	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2
Completed	A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic NCT04198415	AbbVie	—
Recruiting	Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Sma NCT03824483	Memorial Sloan Kettering Cancer Center	Phase 2